Workflow
国药现代(600420) - 2019 Q1 - 季度财报
SHYNDECSHYNDEC(SH:600420)2019-04-25 16:00

Financial Performance - Net profit attributable to shareholders rose by 6.83% to CNY 185,164,751.66 year-on-year [15]. - Operating revenue grew by 2.10% to CNY 3,174,548,215.12 compared to the same period last year [15]. - Basic earnings per share increased by 12.23% to CNY 0.1753 compared to the same period last year [15]. - Net profit for Q1 2019 reached RMB 261,435,748.36, compared to RMB 258,631,262.02 in Q1 2018, showing a growth of 1.1% [48]. - Total profit for Q1 2019 was RMB 315,297,890.33, slightly up from RMB 312,880,410.41 in Q1 2018 [48]. Asset Management - Total assets increased by 0.65% to CNY 16,571,044,102.00 compared to the end of the previous year [15]. - The company's accounts receivable increased by 45.61% to CNY 2,520,148,326.10 compared to the previous year [22]. - Construction in progress increased by 103.44% to CNY 512,695,204.05 due to increased investment in environmental projects [22]. - Total assets increased to ¥16,571,044,102.00 from ¥16,463,864,592.89, reflecting overall growth in the company's asset base [33]. - Total assets increased to ¥9,072,788,038.77 from ¥8,779,184,746.41, an increase of about 3.3% [42]. Cash Flow - Net cash flow from operating activities decreased by 216.17% to -CNY 287,851,789.55 compared to the previous year [15]. - Cash inflow from operating activities reached ¥2,411,032,805.08, compared to ¥2,134,696,092.03 in the same quarter last year, reflecting a growth of approximately 12.96% [60]. - Cash paid for purchasing goods and services was ¥1,171,424,545.36, significantly higher than ¥600,322,396.00 in the same quarter last year, indicating an increase of approximately 95.3% [60]. - The net cash flow from investment activities was -$286.16 million, compared to -$267.93 million in the previous period, indicating a decline in investment cash flow [67]. - The ending balance of cash and cash equivalents was ¥2,918,415,072.39, compared to ¥2,486,680,112.62 at the end of the same quarter last year, representing an increase of approximately 17.3% [62]. Liabilities and Equity - Total liabilities decreased to ¥7,988,246,506.70 from ¥8,020,580,795.44, a reduction of approximately 0.4% [35]. - Current liabilities increased to ¥6,711,768,865.03 from ¥6,568,480,863.79, reflecting an increase of about 2.2% [35]. - Non-current liabilities decreased to ¥1,276,477,641.67 from ¥1,452,099,931.65, a decrease of approximately 12.1% [35]. - Total equity increased to ¥8,582,797,595.30 from ¥8,443,283,797.45, representing an increase of about 1.6% [35]. - Shareholders' equity stood at RMB 6,826,266,493.24, reflecting a strong equity position [80]. Investment and Expenses - The company reported a decrease in financial expenses by 30.41% to CNY 49,553,445.69 compared to the previous year [22]. - Research and development expenses for Q1 2019 were RMB 72,217,689.81, down from RMB 81,945,404.58 in Q1 2018, a decrease of 11.1% [45]. - Sales expenses for Q1 2019 were RMB 1,016,338,837.40, significantly higher than RMB 834,618,046.18 in Q1 2018, an increase of 21.8% [45]. - The company reported an investment loss of RMB 12,009,240.46 in Q1 2019, compared to a gain of RMB 6,479,474.20 in Q1 2018 [45]. - Interest income increased by 77.78% to ¥13,174,902.14 compared to ¥7,410,643.19 in the previous year [24]. Shareholder Information - The number of shareholders reached 27,102 by the end of the reporting period [18]. - The company issued 16,159,400 convertible bonds at ¥100 each, raising a total of ¥161,594,000,000, with net proceeds of ¥1,608,666,189.30 after expenses [25].